Clinical Trial Update: Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone [NA]

View source ↗

Summary

This entry describes a clinical trial evaluating the efficacy and safety of a long-acting risperidone microsphere formulation in schizophrenia and other psychot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizophrenia

Drugs mentioned

• Risperidone long-acting injectable (microsphere formulation) (risperidone)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Schizophrenia, Catatonic, Schizophrenia, Disorganized | NA | Status: UNKNOWN